Status:
RECRUITING
RLE Outcomes With Bilateral Implantation of Odyssey IOLs
Lead Sponsor:
Mann Eye Institute
Collaborating Sponsors:
Sengi
Conditions:
Refractive Lens Exchange
Eligibility:
All Genders
40+ years
Brief Summary
This study is a single center, ambispective study of visual outcomes after successful bilateral implantation of the Odyssey IOL. Subjects will be assessed at least 2 months postoperatively at a single...
Eligibility Criteria
Inclusion
- Participants will include 40 patients aged 40 years and older who have a measurable Potential Acuity Meter (PAM) of 20/20 electing to undergo bilateral refractive lensectomy surgery with IOL implantation.
Exclusion
- Patients with significant ocular comorbidities (e.g., macular degeneration, glaucoma) or prior intraocular surgery will be excluded.
Key Trial Info
Start Date :
July 21 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2026
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06979557
Start Date
July 21 2025
End Date
June 1 2026
Last Update
August 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mann Eye Institute
Houston, Texas, United States, 76134-2099